Literature DB >> 9632613

Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis.

M B Klein1, S F Hayes, J L Goodman.   

Abstract

Human granulocytic ehrlichiosis (HGE) is an emerging tick-borne infection with a specific tropism for granulocytes. We previously isolated and cultivated the HGE agent in the promyelocytic leukemia cell line HL-60 and have also demonstrated the susceptibility of both granulocytic and monocytic human marrow progenitors. Circulating monocytes have not been observed to be infected, suggesting that cell susceptibility may be differentiation specific. To evaluate this hypothesis, HL-60 cells were differentiated towards granulocytes (with dimethyl sulfoxide or all-trans retinoic acid) or toward monocytes-macrophages (with 12-O-tetradecanoylphorbol-13-acetate [TPA], gamma interferon, or 1, 25-dihydroxyvitamin D3) and then challenged with HGE. HGE binding, internalization, and proliferation were compared in differentiated and untreated control HL-60 cells by immunofluorescence, electron microscopy, and Giemsa staining. Granulocytic differentiation resulted in a doubling of HGE binding and enhanced infection consistent with the agent's clinical tropism for neutrophils. Granulocytic cells were unable to kill internalized ehrlichiae even after activation induced by N-formyl-Met-Leu-Phe alone or together with tumor necrosis factor alpha. In contrast, monocyte-macrophage differentiation with TPA resulted in complete resistance to infection through at least two distinct mechanisms: (i) reduction in binding and uptake and (ii) killing of any internalized organisms. Diminished binding in TPA-treated cells correlated with their reduced expression of sialyl Lewis x (CD15s), a putative cellular receptor component for HGE. The degree of monocytic differentiation and activation induced (i.e., TPA > gamma interferon > vitamin D3) correlated with resistance to HGE. Thus, HL-60 cells exhibit a striking differentiation-specific susceptibility to HGE. Differentiation-induced changes in bacterial adhesion and killing capacity underlie the tropism of HGE for granulocytic HL-60 cells and, conversely, the resistance of activated macrophages to infection.

Entities:  

Mesh:

Year:  1998        PMID: 9632613      PMCID: PMC108360     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  SIMPLIFIED MYELOPEROXIDASE STAIN USING BENZIDINE DIHYDROCHLORIDE.

Authors:  L S KAPLOW
Journal:  Blood       Date:  1965-08       Impact factor: 22.113

2.  Human infection with Ehrlichia canis, a leukocytic rickettsia.

Authors:  K Maeda; N Markowitz; R C Hawley; M Ristic; D Cox; J E McDade
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

3.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

4.  Gamma interferon induces monocytoid differentiation in the HL-60 cell line.

Authors:  E D Ball; P M Guyre; L Shen; J M Glynn; C R Maliszewski; P E Baker; M W Fanger
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 5.  Phorbol diesters and cellular differentiation.

Authors:  G R Vandenbark; J E Niedel
Journal:  J Natl Cancer Inst       Date:  1984-11       Impact factor: 13.506

6.  1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells.

Authors:  D M McCarthy; J F San Miguel; H C Freake; P M Green; H Zola; D Catovsky; J M Goldman
Journal:  Leuk Res       Date:  1983       Impact factor: 3.156

7.  Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.

Authors:  G Rovera; D Santoli; C Damsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

8.  Effect of phorbol esters on iron uptake in human hematopoietic cell lines.

Authors:  U Testa; M Titeux; F Louache; P Thomopoulos; H Rochant
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

9.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation.

Authors:  P E Newburger; M E Chovaniec; J S Greenberger; H J Cohen
Journal:  J Cell Biol       Date:  1979-08       Impact factor: 10.539

View more
  5 in total

1.  Binding of the Streptococcus gordonii DL1 surface protein Hsa to the host cell membrane glycoproteins CD11b, CD43, and CD50.

Authors:  Yumiko Urano-Tashiro; Ayako Yajima; Eizo Takashima; Yukihiro Takahashi; Kiyoshi Konishi
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

2.  Sodium valproate facilitates the propagation of granulocytic ehrlichiae (Anaplasma phagocytophilum) in HL-60 cells.

Authors:  Petir Zeman; Jaroslav Cinatl; Hana Kabickova
Journal:  Exp Appl Acarol       Date:  2002       Impact factor: 2.132

3.  NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.

Authors:  Jessica N Nichol; Matthew D Galbraith; Claudia L Kleinman; Joaquín M Espinosa; Wilson H Miller
Journal:  Cell Rep       Date:  2016-03-17       Impact factor: 9.423

4.  Cultivation of Anaplasma ovis in the HL-60 human promyelocytic leukemia cell line.

Authors:  Ran Wei; Hong-Bo Liu; Frans Jongejan; Bao-Gui Jiang; Qiao-Cheng Chang; Xue Fu; Jia-Fu Jiang; Na Jia; Wu-Chun Cao
Journal:  Emerg Microbes Infect       Date:  2017-09-20       Impact factor: 7.163

5.  The Novel Zoonotic Pathogen, Anaplasma capra, Infects Human Erythrocytes, HL-60, and TF-1 Cells In Vitro.

Authors:  Yongshuai Peng; Chenyang Lu; Yaqun Yan; Jinxing Song; Zhiyang Pei; Pihong Gong; Rongjun Wang; Longxian Zhang; Fuchun Jian; Changshen Ning
Journal:  Pathogens       Date:  2021-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.